We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOEV
1301
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$120K 0.02%
+34
New +$136K
IS
1302
DELISTED
ironSource Ltd.
IS
$120K 0.02%
+15,557
New +$153K
GRDX
1303
GridAI Technologies Corp
GRDX
$19.2M
$118K 0.01%
+6
New +$164K
CRK icon
1304
Comstock Resources
CRK
$3.94B
$115K 0.01%
14,230
-116,809
-89% -$1.07M
CANO
1305
DELISTED
Cano Health, Inc.
CANO
$115K 0.01%
129
+23
+22% +$24.2K
BDSI
1306
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$111K 0.01%
35,647
-249,449
-87% -$839K
NNDM
1307
Nano Dimension
NNDM
$343M
$110K 0.01%
+29,007
New +$147K
TYME
1308
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$109K 0.01%
+180,823
New +$155K
BIOR
1309
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$108K 0.01%
207
-2,253
-92% -$1.62M
SB icon
1310
Safe Bulkers
SB
$774M
$105K 0.01%
27,789
-23,628
-46% -$96.3K
CRIS icon
1311
Curis
CRIS
$7.83M
$103K 0.01%
+54
New +$128K
KUST
1312
Kustom Entertainment Inc
KUST
$759K
0
FTI icon
1313
TechnipFMC
FTI
$27.3B
$103K 0.01%
+17,450
New +$120K
TAL icon
1314
TAL Education Group
TAL
$6.87B
$99K 0.01%
+25,279
New +$114K
ESRT icon
1315
Empire State Realty Trust
ESRT
$836M
$94K 0.01%
+10,542
New +$104K
CRDF icon
1316
Cardiff Oncology
CRDF
$77.2M
$93K 0.01%
+15,512
New +$92.5K
HYLN icon
1317
Hyliion Holdings
HYLN
$690M
$92K 0.01%
+14,830
New +$106K
OCFT
1318
DELISTED
OneConnect Financial Technology
OCFT
$90K 0.01%
+3,648
New +$108K
OIS icon
1319
Oil States International
OIS
$491M
$89K 0.01%
17,869
-32,897
-65% -$194K
ASLN
1320
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$89K 0.01%
+1,984
New +$119K
ZNGA
1321
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$89K 0.01%
+13,868
New +$95.7K
BYSI icon
1322
BeyondSpring
BYSI
$35.8M
$83K 0.01%
+18,413
New +$208K
XXII
1323
22nd Century Group
XXII
$1.48M
0
GMDA
1324
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$83K 0.01%
+32,548
New +$107K
HOOK
1325
DELISTED
HOOKIPA Pharma
HOOK
$81K 0.01%
+3,473
New +$140K

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.